Galanin

Discovery and Distribution

Galanin was isolated in 1983 from porcine intestine by Tatemoto and colleagues using a chemical isolation approach based on C-terminal amidation screening. The name derives from its N-terminal glycine and C-terminal alanine residues. Galanin is one of the most widely distributed neuropeptides in the mammalian nervous system, with dense fiber projections in the hypothalamus, hippocampus, spinal cord, and brainstem. Peripheral distribution includes enteric neurons, pancreatic islets, and adrenal medulla.

Structure and Receptor System

Mammalian galanin comprises 30 amino acids, with the sequence: Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Asp-Gly-Asn-Arg-Ser-Arg-Ser-Asp-His-Asn-Lys-Gly-Leu-Ala-NH2. The N-terminal fragment (1-16) is highly conserved across species and essential for receptor binding, while the C-terminal region is more variable and influences receptor subtype selectivity. Three receptor subtypes have been identified: GalR1 (Gi-coupled, inhibiting adenylyl cyclase), GalR2 (Gq-coupled, activating phospholipase C), and GalR3 (Gi-coupled, with distinct tissue distribution).

Pain Modulation

Galanin exhibits complex modulatory effects on nociceptive processing. In dorsal root ganglion neurons, GalR1 activation inhibits substance P release and attenuates nociceptive transmission. Intrathecal galanin produces analgesia in inflammatory and neuropathic pain models. However, galanin can also facilitate pain under certain conditions through GalR2 activation, suggesting a bidirectional modulatory role. Galanin expression is upregulated in dorsal root ganglion neurons following peripheral nerve injury, representing an endogenous neuroprotective mechanism.

Feeding Behavior and Energy Balance

Galanin potently stimulates food intake when administered into the hypothalamic paraventricular nucleus, particularly promoting consumption of dietary fat. Galanin expression in the arcuate nucleus is regulated by nutritional status, increasing during fasting and decreasing with refeeding. The peptide interacts with neuropeptide Y and orexin systems to coordinate feeding behavior. Genetic studies have identified galanin gene polymorphisms associated with body mass index variation in human populations.

Cognitive Functions

Galanin modulates cholinergic neurotransmission in the basal forebrain, generally exerting inhibitory effects on learning and memory. GalR1 antagonists have shown procognitive effects in animal models of Alzheimer disease, making galanin receptor antagonism a promising therapeutic strategy. However, the relationship is complex, as galanin also promotes neuronal survival and plasticity following injury.

References

1. Tatemoto K, Rokaeus A, Jornvall H, et al. Galanin: a novel biologically active peptide from porcine intestine. FEBS Letters. 1983;164:124-128.
2. Lang R, Gundlach AL, Holmes FE, et al. Physiology, signaling, and pharmacology of galanin receptors. Pharmacological Reviews. 2015;67:118-175.
3. Counts SE, Perez SE, Ginsberg SD, et al. Galanin in Alzheimer disease. Molecular Interventions. 2003;3:137-156.